NOAEL Studies
Cosmetic Ingredient
Camphor Benzalkonium Methosulfate NOAEL Studies
INCI: CAMPHOR BENZALKONIUM METHOSULFATE
CAS: 52793-97-2
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 300 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; O. Boutherin-Falson. Mexoryl SO – 13 week oral (gavage) toxicity study in the rat followed by a 4 week treatment-free period. MDS Pharma Services Study No. AA21484, 2005 |
| COSMOS DB | NOAEL | 100 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; O. Boutherin-Falson. Mexoryl SO – 13 week oral (gavage) toxicity study in the rat followed by a 4 week treatment-free period. MDS Pharma Services Study No. AA21484, 2005 |
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.819 | mg/kg | rat | oral | 90-day | dermal absorption | (ref. 20), p.22 |
| SCCS Opinion | NOAEL | =3 | % | - | dermal | - | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =89.1 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =300 | mg/kg/day | rat | oral | 13 weeks | NOAEL study | p.13 |
| SCCS Opinion | NOAEL | =300 | mg/kg/day | rat | oral | 13 weeks | genotoxicity | p.14 |
| SCCS Opinion | NOAEL | =1000 | mg/kg/day | rat | - | developmental | developmental toxicity | p.17 |
Regulatory source 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 300 | mg/kg/day | rat | oral | 13 weeks | - | p.13 |
| Regulatory source | dermal absorption | =0.819 | mg/kg | rat | oral | 90-day | dermal absorption | p.22 |
| Regulatory source | dermal absorption | 3 | % | - | dermal | - | dermal absorption | p.22 |
| Regulatory source | dermal absorption | =89.1 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.22 |
| Regulatory source | developmental toxicity | 300 | mg/kg/day | guinea pig | - | 90-day | developmental toxicity | p.22 |
| Regulatory source | developmental toxicity | 1000 | mg/kg/day | rat | - | developmental | developmental toxicity | p.17 |
| Regulatory source | developmental toxicity | 1000 | mg/kg/day | guinea pig | dermal | 90-day | developmental toxicity | p.22 |
| Regulatory source | genotoxicity | 300 | mg/kg/day | rat | oral | 13 weeks | genotoxicity | p.13 |